Iotalamic acid
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | V08AA04 (WHO) |
Identifiers | |
| |
PubChem (CID) | 3737 |
ChemSpider | 3606 |
UNII | 16CHD79MIX |
KEGG | D01258 |
ECHA InfoCard | 100.017.181 |
Chemical and physical data | |
Formula | C11H9I3N2O4 |
Molar mass | 613.91357 |
3D model (Jmol) | Interactive image |
| |
|
Iotalamic acid (also iothalamic acid in USAN) and its salts (INN Iothalamates) is an iodine-containing organic anion used as a radiocontrast agent. It is available as sodium iothalamate (Iothalamate sodium) and meglumine iothalamate (Iothalmate meglumine). It can be administered intravenously or intravesically (into the urinary bladder).[1]
Radioactive formulation is also available as sodium iothalamate I-125 Injection (GLOFIL-125). It is indicated for evaluation of glomerular filtration in the diagnosis or monitoring of patients with renal disease.[1]
References
- 1 2 "Iothalamate Meglumine and Iothalamate Sodium Drug Information, Professional". www.drugs.com. Retrieved 2016-07-16.
This article is issued from Wikipedia - version of the 7/22/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.